SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001178913-22-002219
Filing Date
2022-05-27
Accepted
2022-05-27 16:28:54
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 zk2227913.htm S-3 476459
2 EXHIBIT 1.2 exhibit_1-2.htm EX-1.2 198971
3 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 311845
4 EXHIBIT 4.2 exhibit_4-2.htm EX-4.2 326652
5 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 26040
6 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 27397
7 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 6119
8 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 63906
9 image0.jpg GRAPHIC 76115
10 image1.jpg GRAPHIC 84308
11 image2.jpg GRAPHIC 75730
12 image00003.jpg GRAPHIC 17870
13 image3.jpg GRAPHIC 5943
  Complete submission text file 0001178913-22-002219.txt   1796768
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265286 | Film No.: 22978045
SIC: 2836 Biological Products, (No Diagnostic Substances)